page | More news on rituximab and COVID-19 | rheumatology.medicinematters.com

Medicine Matters Rheumatology

Medicine Matters Rheumatology

More news on rituximab and COVID-19

07-01-2022 | COVID-19 | News

Rituximab and COVID-19 vaccination: Timing may be key for antibody response

10-12-2021 | COVID-19 | News

Only rituximab, not other immunosuppressants, associated with poor COVID-19 outcomes

30-11-2021 | COVID-19 | News

B-cell levels may govern success of COVID-19 vaccine booster in rituximab-treated patients

09-11-2021 | ACR 2021 | Conference coverage | News

COVID-19 vaccine response factors identified in rituximab-treated patients

16-09-2021 | COVID-19 | News

Low rates of breakthrough SARS-CoV-2 infection after vaccination in people with RMDs

13-09-2021 | COVID-19 | News

Study identifies predictors of COVID-19 vaccine response in rituximab-treated patients

07-09-2021 | COVID-19 | News

COVID-19 vaccination: Meta-analysis confirms reduced seroconversion rates in people with IMIDs

06-09-2021 | COVID-19 | News

Glucocorticoids, B-cell depleting therapies may dampen immune response to COVID-19 vaccines

23-06-2021 | COVID-19 | News

‘Significant humoral response’ following two COVID-19 vaccine doses in RMD patients

07-06-2021 | EULAR 2021 | Conference coverage | News

BIOCOV study supports rituximab link to severe COVID-19

02-06-2021 | EULAR 2021 | Conference coverage | News

Rituximab, JAK inhibitors linked to worse COVID-19 severity in RA patients

11-05-2021 | COVID-19 | News

Rituximab treatment ‘may not preclude’ COVID-19 vaccination

31-03-2021 | COVID-19 | News

Most RMD patients have antibody response to COVID-19 vaccination

30-03-2021 | COVID-19 | News

Rituximab use may be a risk factor for severe COVID-19

04-02-2021 | COVID-19 | News

Disease activity linked to COVID-19 mortality risk in rheumatology patients

16-12-2020 | COVID-19 | News

Patients with rheumatic diseases may not have elevated COVID-19 mortality risk

28-05-2020 | Systemic lupus erythematosus | News

Lupus therapies may not impact COVID-19 outcomes

23-04-2020 | COVID-19 | News

COVID-19: Immune effects of rituximab require further investigation